1. Home
  2. RH vs IDYA Comparison

RH vs IDYA Comparison

Compare RH & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RH

RH

RH

HOLD

Current Price

$171.41

Market Cap

3.2B

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$34.37

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RH
IDYA
Founded
1979
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.9B
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
RH
IDYA
Price
$171.41
$34.37
Analyst Decision
Hold
Strong Buy
Analyst Count
16
14
Target Price
$227.33
$49.42
AVG Volume (30 Days)
1.2M
1.0M
Earning Date
12-11-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
57.11
N/A
EPS
5.52
N/A
Revenue
$3,409,319,000.00
$214,834,000.00
Revenue This Year
$13.15
$2,434.86
Revenue Next Year
$10.14
N/A
P/E Ratio
$30.96
N/A
Revenue Growth
9.74
5377.66
52 Week Low
$123.03
$13.45
52 Week High
$455.84
$37.08

Technical Indicators

Market Signals
Indicator
RH
IDYA
Relative Strength Index (RSI) 58.48 52.66
Support Level $151.71 $33.11
Resistance Level $181.72 $34.45
Average True Range (ATR) 8.94 1.38
MACD 2.60 -0.31
Stochastic Oscillator 66.47 18.97

Price Performance

Historical Comparison
RH
IDYA

About RH RH

RH is a luxury furniture and lifestyle retailer operating in the $136 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories including furniture, lighting, textiles, bath, decor, and children and is growing the presence of its hospitality business with 23 restaurant locations, including RH Guesthouse. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade via expanding abroad, its World of RH digital platform (highlighting offerings outside of home furnishings), and offerings in architecture, media, and more.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: